Join us   Log in   ijesmj@gmail.com  


INTERNATIONAL JOURNAL OF ENGINEERING, SCIENCE AND - Volume 5, Issue 2 , June 2016

Pages: 86-94

Date of Publication: 01-Jun-2016


Print Article   Download XML  Download PDF

DOSES FOR ORGANS AT RISK FOR PATIENT UNDERGOING MAMMOSITE OR INTERSTITIAL LEFT BREAST BRACHYTHERAPY 1500

Author: MAHMOUD SULEIMAN A. DAHOUD* ISKANDAR SHAHRIM MUSTAFA**

Category: Engineering, Science and Mathematics

Abstract:

The increasing number of breast cancer cases over the world motivates researchers to do their effort in development of a safe radiation therapy that has the ability to target the tumor itself and spare adjacent organs. The recommendations of science communities give a wide choice for physicians and patients to choose a suitable and safe brachytherapy technique to cure breast cancer cases. The eyes of scientists are looking for a technique by which tumor cells can be destroyed, as fast and effective as it must be safe for patients and workers. Many different researchers gave different opinions for using one way of radiation therapy in curing breast cancer on tumor cells or used treatment plan readings to compare doses to internal organs and tissues. The need for a comprehensive view on doses delivered by one of the breast brachytherapy techniques (MammoSite single lumen balloon brachytherapy system (MBS) and multicatheter interstitial brachytherapy (MIB)) to adjacent organs and tissues is the way to avoid the recurrence of cancer or destroy some organs. The safe technique is the most appropriate way for healthy tissues and organs by which receive lowest amount of radiation. The dosimetric comparison between mentioned methods inside human phantom is by the use of high sensitive dosimeter TLD 100H at positions of organs at risk (OARs) then data can be collected and comparisons will be made.

Keywords: MammoSite, Interstitial, Brachytherapy, Treatment Plan, TLD 100H, OARs